3679 related articles for article (PubMed ID: 7597286)
1. Mutation and expression of TP53 in malignant melanomas.
Weiss J; Heine M; Arden KC; Körner B; Pilch H; Herbst RA; Jung EG
Recent Results Cancer Res; 1995; 139():137-54. PubMed ID: 7597286
[TBL] [Abstract][Full Text] [Related]
2. Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: an update.
Reichrath J; Rass K
Adv Exp Med Biol; 2014; 810():208-33. PubMed ID: 25207368
[TBL] [Abstract][Full Text] [Related]
3. p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanomagenesis.
Zerp SF; van Elsas A; Peltenburg LT; Schrier PI
Br J Cancer; 1999 Feb; 79(5-6):921-6. PubMed ID: 10070891
[TBL] [Abstract][Full Text] [Related]
4. Overexpression and mutations of p53 in metastatic malignant melanomas.
Hartmann A; Blaszyk H; Cunningham JS; McGovern RM; Schroeder JS; Helander SD; Pittelkow MR; Sommer SS; Kovach JS
Int J Cancer; 1996 Jul; 67(3):313-7. PubMed ID: 8707401
[TBL] [Abstract][Full Text] [Related]
5. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.
Liu-Smith F; Jia J; Zheng Y
Adv Exp Med Biol; 2017; 996():27-40. PubMed ID: 29124688
[TBL] [Abstract][Full Text] [Related]
6. Mutation and expression of the p53 gene in malignant melanoma cell lines.
Weiss J; Schwechheimer K; Cavenee WK; Herlyn M; Arden KC
Int J Cancer; 1993 Jun; 54(4):693-9. PubMed ID: 8514460
[TBL] [Abstract][Full Text] [Related]
7. P53 and hMSH2 expression in basal cell carcinomas and malignant melanomas from photoexposed areas of head and neck region.
Staibano S; Lo Muzio L; Pannone G; Somma P; Farronato G; Franco R; Bambini F; Serpico R; De Rosa G
Int J Oncol; 2001 Sep; 19(3):551-9. PubMed ID: 11494035
[TBL] [Abstract][Full Text] [Related]
8. p53 protein expression and TP53 mutations in malignant melanomas of sun-sheltered mucosal membranes versus chronically sun-exposed skin.
Ragnarsson-Olding B; Platz A; Olding L; Ringborg U
Melanoma Res; 2004 Oct; 14(5):395-401. PubMed ID: 15457096
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of p53 overexpression in cutaneous melanoma from sun-exposed and nonexposed sites.
Essner R; Kuo CT; Wang H; Wen DR; Turner RR; Nguyen T; Hoon DS
Cancer; 1998 Jan; 82(2):309-16. PubMed ID: 9445187
[TBL] [Abstract][Full Text] [Related]
10. Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies.
Moch C; Moysan A; Lubin R; de la Salmonière P; Soufir N; Galisson F; Vilmer C; Venutolo E; Le Pelletier F; Janin A; Basset-Séguin N
Br J Cancer; 2001 Dec; 85(12):1883-6. PubMed ID: 11747330
[TBL] [Abstract][Full Text] [Related]
11. Expression of p53 protein in malignant melanoma: clinicopathological and prognostic implications.
Weiss J; Heine M; Körner B; Pilch H; Jung EG
Br J Dermatol; 1995 Jul; 133(1):23-31. PubMed ID: 7669636
[TBL] [Abstract][Full Text] [Related]
12. Frequent p53 alterations but low incidence of ras mutations in UV-B-induced skin tumors of hairless mice.
van Kranen HJ; de Gruijl FR; de Vries A; Sontag Y; Wester PW; Senden HC; Rozemuller E; van Kreijl CF
Carcinogenesis; 1995 May; 16(5):1141-7. PubMed ID: 7767977
[TBL] [Abstract][Full Text] [Related]
13. Retinoblastoma gene expression in human non-melanoma skin cancer.
Edwards MJ; Thomas RC; Wong YL
J Cutan Pathol; 2003 Sep; 30(8):479-85. PubMed ID: 12950498
[TBL] [Abstract][Full Text] [Related]
14. p53 expression is rare in cutaneous melanomas.
Saenz-Santamaría MC; McNutt NS; Bogdany JK; Shea CR
Am J Dermatopathol; 1995 Aug; 17(4):344-9. PubMed ID: 8600797
[TBL] [Abstract][Full Text] [Related]
15. p53 gene mutation and expression in naevi and melanomas.
Sparrow LE; Soong R; Dawkins HJ; Iacopetta BJ; Heenan PJ
Melanoma Res; 1995 Apr; 5(2):93-100. PubMed ID: 7620345
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of p53 over-expression in thin melanomas.
Sparrow LE; English DR; Heenan PJ; Dawkins HJ; Taran J
Melanoma Res; 1995 Dec; 5(6):387-92. PubMed ID: 8589612
[TBL] [Abstract][Full Text] [Related]
17. [The tumor suppressor gene p53 and its significance for dermatology].
Lübbe J; Kleihues P; Burg G
Hautarzt; 1994 Nov; 45(11):741-5. PubMed ID: 7822196
[TBL] [Abstract][Full Text] [Related]
18. Expression of p53 protein is an early event in ultraviolet light-induced cutaneous squamous cell carcinogenesis.
Nagano T; Ueda M; Ichihashi M
Arch Dermatol; 1993 Sep; 129(9):1157-61. PubMed ID: 8363400
[TBL] [Abstract][Full Text] [Related]
19. Point mutations and allelic loss in the TP53 locus of cutaneous malignant melanomas.
Weiss J; Cavenee WK; Herbst RA; Jung EG; Arden KC
Arch Dermatol Res; 1994; 286(7):417-9. PubMed ID: 7818283
[No Abstract] [Full Text] [Related]
20. Relationship of p53 mutations to epidermal cell proliferation and apoptosis in human UV-induced skin carcinogenesis.
Einspahr JG; Alberts DS; Warneke JA; Bozzo P; Basye J; Grogan TM; Nelson MA; Bowden GT
Neoplasia; 1999 Nov; 1(5):468-75. PubMed ID: 10933063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]